Skip to main content

Table 2 Biochemical factors investigated and categorizing

From: Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid

Biochemical factor

category

No.

%

Baseline NTx

normal

≤ 18 nM BCE

30

50

 

abnormal

> 18 nM BCE

30

50

Baseline VEGF

normal

≤ 500 pg/ml

30

50

 

abnormal

> 500 pg/ml

30

50

Baseline CEA

normal

≤ 10 μg/L

42

70

 

abnormal

> 10 μg/L

18

30

Baseline CA 15-3

normal

≤ 51 U/mL

21

35

 

abnormal

> 51 U/mL

39

65

NTx (days 90)

normal

≤ 18 nM BCE

34

56.7

 

abnormal

> 18 nM BCE

16

43.3

VEGF (days 90)

normal

≤ 500 pg/ml

29

48.3

 

abnormal

> 500 pg/ml

21

42.7